Study integrates genetic data and networks to identify pathways in Alzheimer’s disease, suggesting new insights into susceptibility.
To integrate GWAS-identified Alzheimer’s disease variants with functional and network-level data to identify convergent molecular pathways underlying disease susceptibility.
No takes yet. Share an insight, caveat, or question.
Martinez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: